DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Erbitux (Cetuximab) - Current Clinical Trials

 
 



Erbitux Related Clinical Trials

Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer [Active, not recruiting]

Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer [Active, not recruiting]

Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Pancreatic Cancer [Suspended]

Study of Erbituxâ„¢ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors [Completed]

FLOX in Combination With Cetuximab in First-Line Treatment of Colorectal Cancer [Active, not recruiting]

Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer [Active, not recruiting]

Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma [Completed]

An Observational Study of Erbitux® in Patients With Metastatic Colorectal Cancer (mCRC) Refractory to Irinotecan-containing Treatment [Recruiting]

Cetuximab+RO4929097 & Ph2 Cetuximab+RO4929097 vs Cetuximab+Placebo in Metastatic Colorectal Cancer [Not yet recruiting]

PI Cetuximab w/ RO4929097/PII Cetuximab w/RO4929097 vs Cetuximab w/ Placebo (16245) [Not yet recruiting]

Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer [Recruiting]

Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer [Recruiting]

A Post-marketing Surveillance Study of Erbitux (Cetuximab) in Combination With Radiotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) [Not yet recruiting]

An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck [Recruiting]

A Trial of Erbitux for Recurrent and Metastatic Mucinous Gastrointestinal Adenocarcinoma Involving the Peritoneal Surfaces [Completed]

A Trial Exploring the Efficacy of EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Na�ve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) [Recruiting]

EMMA-1 (Erbitux for Multiple Myeloma) [Recruiting]

A Post-marketing Surveillance Study on Erbitux in Combination With Platinum-based Chemotherapy in Metastatic/Recurrent Squamous Cell Cancer of the Head and Neck [Recruiting]

Study Evaluating the Safety and Efficacy of FOLFIRI Plus Cetuximab (Erbitux) or FOLFOX Plus Cetuximab as First-line Therapy in Subjects With KRAS Wild-type Metastatic Colorectal Cancer (APEC-Study) [Recruiting]

Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma [Recruiting]

Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC [Recruiting]

Phase 1 and 2 Study of PX-866 and Cetuximab [Recruiting]

ERBITUX� Followed by Adjuvant Treatment With Chemoradiation and ERBITUX� for Locally Advanced Head and Neck Squamous Cell Carcinoma [Recruiting]

Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors [Recruiting]

Cetuximab Standard or Dose Escalation in First Line Colorectal Cancer [Recruiting]

Safety and Efficacy Study of mFOLFOX-6 Plus Cetuximab for 8 Cycles Followed by mFOLFOX-6 Plus Cetuximab or Single Agent Cetuximab as Maintenance Therapy in Patients With Metastatic Colorectal Cancer and WT KRAS Tumours [Recruiting]

Study of Imprime PGG� in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer [Recruiting]

A Korean Post-marketing Surveillance Study on Erbitux® in Patients With Metastatic Colorectal Cancer Refractory to Irinotecan-containing Treatment [Recruiting]

External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas [Recruiting]

Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE) [Active, not recruiting]

Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib [Not yet recruiting]

Trial of OTD70DERM® in Radio-dermatitis Induced by Radiotherapy-Erbitux® [Recruiting]

A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Recruiting]

BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies [Active, not recruiting]

Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed By Surgery [Recruiting]

Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC) [Not yet recruiting]

Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy [Not yet recruiting]

Prospective, Post Marketing Surveillance Study On Erbitux® (Cetuximab) in Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck in Korea [Recruiting]

ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Subjects With KRAS Wild-Type Metastatic Colorectal Cancer [Recruiting]

Bevacizumab, Temsirolimus, Valproic Acid, Cetuximab [Recruiting]

Paclitaxel, Carboplatin and Cetuximab (PCC) Versus Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) [Recruiting]

Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma [Recruiting]

Vemurafenib, Cetuximab, and Irinotecan in Advanced Solid Cancers [Not yet recruiting]

FLOX + Cetuximab (Erbitux®) for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS Tumor [Recruiting]

Erlotinib in Combination With Cetuximab [Recruiting]

Treatment Optimization of Cetuximab in Patients With Metastatic Colorectal Cancer Based on Tumor Uptake of 89Zr-labeled Cetuximab Assessed by PET [Recruiting]

Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer [Completed]

Cetuximab Alone and Cetuximab With Carboplatin in ER/PR-Negative, HER-2 Nonoverexpressing Metastatic Breast Cancer [Recruiting]

Cetuximab in Treating Patients With Advanced Solid Tumors [Completed]

Surgery Followed by Chemoradiotherapy Plus Cetuximab for Squamous Cell Carcinoma of the Head and Neck. [Terminated]

Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer. [Active, not recruiting]

Cetuximab Combined With Irinotecan in First-Line Therapy for Metastatic Colorectal Cancer (CRYSTAL) [Active, not recruiting]

Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer [Completed]

Cetuximab and Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer

Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced or Regional Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery

Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Head and Neck Cancer [Active, not recruiting]

Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer

A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer [Recruiting]

PhII ICb With/Without Erbitux in MBC Pts [Recruiting]

CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-Cell Lung Cancer [Active, not recruiting]

Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy [Recruiting]

Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer [Recruiting]

Safety and Efficacy of Folfox4 + Weekly Cetuximab vs Folfox 4+Biweekly Cetuximab by Metastatic Colorectal Cancer [Not yet recruiting]

Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer [Recruiting]

Phase I Cetuximab and Concurrent Radio-Chemotherapy [Recruiting]

Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer [Recruiting]

Sorafenib and Cetuximab in Treating Patients With Metastatic Colorectal Cancer [Recruiting]

Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma [Recruiting]

An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer [Completed]

An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma [Completed]

Phase II Study of XELOX With Cetuximab in Advanced AGC [Recruiting]

Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors or Progressive or Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer [Recruiting]

Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer [Recruiting]

Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer [Completed]

Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients [Recruiting]

Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer [No longer recruiting]

Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [No longer recruiting]

Study of Erbitux (Cetuximab) Given Alone to Patients With EGFR-Undetectable Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy [Recruiting]

Cetuximab and Carbo for ER/PR/HER2 Negative BC [Active, not recruiting]

Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC) [Recruiting]

Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [No longer recruiting]

Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer [No longer recruiting]

Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer [Recruiting]

Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck [Recruiting]

Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer [No longer recruiting]

Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer [Recruiting]

Fluorouracil and Leucovorin Plus Either Irinotecan or Oxaliplatin With or Without Cetuximab in Treating Patients With Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum [Active, not recruiting]

Phase I/II Combination With Irinotecan- Erbitux [Recruiting]

Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer [Recruiting]

A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma [Recruiting]

Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer [Recruiting]

A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer [Recruiting]

Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib [Recruiting]

Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC [Recruiting]

A Phase 2a/2b Multicenter, Open-Label Study to Evaluate NKTR 102 (PEG-Irinotecan) in Combination With Cetuximab Versus Irinotecan in Combination With Cetuximab in Second Line Colorectal Cancer Patients [Recruiting]

Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab. [Recruiting]

Study of IMC-A12, Alone or in Combination With Cetuximab, in Patients With Recurrent or Metastatic Squamous Cell Carcinoma (MSCC) of the Head and Neck [Recruiting]

Gemcitabine, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery [Not yet recruiting]

Study of Cisplatin/Vinorelbine +/- Cetuximab as First-Line Treatment of Advanced Non Small Cell Lung Cancer(FLEX) [Completed]

Preoperative Chemoradiation With Capecitabine and Cetuximab [Active, not recruiting]

Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma [Active, not recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014